Hereditary hemochromatosis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1763, Issue 7, 2006, Pages 700-710

  Pietrangelo, Antonello ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Ferroportin; Hemojuvelin; Hepcidin; HFE; Iron overload; Transferrin receptor 2

Indexed keywords

CERULOPLASMIN; FERROPORTIN 1; HEMOGLOBIN; HEMOJUVELIN; HEPCIDIN; HFE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; TELOMERIC REPEAT BINDING FACTOR 2; TRANSFERRIN; TRANSFERRIN RECEPTOR 2; UPSTREAM STIMULATORY FACTOR 2;

AMINO TERMINAL SEQUENCE; AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; AUTOSOMAL RECESSIVE INHERITANCE; CARBOXY TERMINAL SEQUENCE; ERYTHROPOIESIS; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; GENETIC VARIABILITY; HEMOCHROMATOSIS; HEMOSIDEROSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFLAMMATION; INTERNALIZATION; INTESTINE CELL; IRON ABSORPTION; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON OVERLOAD; IRON RESPONSIVE ELEMENT; IRON STORAGE; IRON TRANSPORT; LIVER CELL; METABOLIC DISORDER; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; TRANSCRIPTION REGULATION;

CATION TRANSPORT PROTEINS; HEMOCHROMATOSIS; HUMANS;

EID: 33746868342     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2006.05.013     Document Type: Review

References (83)

1. von Recklinghausen F.D. Uber Haemochromatose, Taggeblatt der (62) Versammlung deutscher Naturforscher and Aerzte in Heidelberg (1889) 324-325
2. Trousseau A. Glycosurie; diabete sucre. Clinique Med de l'Hotel de Paris 2 (1865) 663-698
3. Troisier M. Diabète sucré. Bull. Soc. Anat. Paris 44 (1871) 231-235
4. Sheldon J. Haemochromatosis (1935), Oxford Univ. Press, London
5. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., Dormishian F., Domingo R., Ellis M.C., Fullan A., Hinton L.M., Jones N.L., Kimmel B.E., Kronmal G.S., Lauer P., Lee V.K., Loeb D.B., Mapa F.A., Mcclelland E., Meyer N.C., Mintier G.A., Moeller N., Moore T., Morikang E., Prass C.E., Quintana L., Starnes S.M., Schatzman R.C., Brunke K.J., Drayna D.T., Risch N.J., Bacon B.R., and Wolff R.K. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13 (1996) 399-408
6. Merryweatherclarke A.T., Pointon J.J., Shearman J.D., and Robson K.J.H. Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34 4 (1997) 275-278
7. Pietrangelo A. Hereditary hemochromatosis-A new look at an old disease. N. Engl. J. Med. 350 (2004) 2383-2397
8. Camaschella C., Roetto A., Cali A., De Gobbi M., Garozzo G., Carella M., Majorano N., Totaro A., and Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 25 (2000) 14-15
9. Roetto A., Papanikolaou G., Politou M., Alberti F., Girelli D., Christakis J., Loukopoulos D., and Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33 (2003) 21-22
10. Papanikolaou G., Samuels M.E., Ludwig E.H., MacDonald M.L., Franchini P.L., Dube M.P., Andres L., MacFarlane J., Sakellaropoulos N., Politou M., Nemeth E., Thompson J., Risler J.K., Zaborowska C., Babakaiff R., Radomski C.C., Pape T.D., Davidas O., Christakis J., Brissot P., Lockitch G., Ganz T., Hayden M.R., and Goldberg Y.P. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36 (2004) 77-82
11. Montosi G., Donovan A., Totaro A., Garuti C., Pignatti E., Cassanelli S., Trenor C.C., Gasparini P., Andrews N.C., and Pietrangelo A. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J. Clin. Invest. 108 (2001) 619-623
12. Njajou O.T., Vaessen N., Joosse M., Berghuis B., van Dongen J.W., Breuning M.H., Snijders P.J., Rutten W.P., Sandkuijl L.A., Oostra B.A., van Duijn C.M., and Heutink P. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat. Genet. 28 (2001) 213-214
13. Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/omim/.
14. Merryweather-Clarke A.T., Cadet E., Bomford A., Capron D., Viprakasit V., Miller A., McHugh P.J., Chapman R.W., Pointon J.J., Wimhurst V.L., Livesey K.J., Tanphaichitr V., Rochette J., and Robson K.J. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum. Mol. Genet. 12 (2003) 2241-2247
15. Pietrangelo A., Caleffi A., Henrion J., Ferrara F., Corradini E., Kulaksiz H., Stremmel W., Andreone P., and Garuti C. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes. Gastroenterology 128 (2005) 470-479
16. Pietrangelo A. The ferroportin disease. Blood Cells Mol. Diseases 32 (2004) 131-138
17. Crosby W.H., Conrad Jr. M.E., and Wheby M.S. The rate of iron accumulation in iron storage disease. Blood 22 (1963) 429-440
18. Lynch S.R., Skikne B.S., and Cook J.D. Food iron absorption in idiopathic hemochromatosis. Blood 74 (1989) 2187-2193
19. Smith P.M., Godfrey B.E., and Williams R. Iron absorption in idiopathic haemochromatosis and its measurement using a whole-body counter. Clin. Sci. 37 (1969) 519-531
20. Crosby W.H. The control of iron balance by the intestinal mucosa. Blood 22 (1963) 441-449
21. Bothwell T.H. Overview and mechanisms of iron regulation. Nutr. Rev. 53 (1995) 237-245
22. Krause A., Neitz S., Magert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., and Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480 (2000) 147-150
23. Park C.H., Valore E.V., Waring A.J., and Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276 (2001) 7806-7810
24. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., and Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276 (2001) 7811-7819
25. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., and Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8780-8785
26. Courselaud B., Pigeon C., Inoue Y., Inoue J., Gonzalez F.J., Leroyer P., Gilot D., Boudjema K., Guguen-Guillouzo C., Brissot P., Loreal O., and Ilyin G. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J. Biol. Chem. 277 (2002) 41163-41170
27. Nicolas G., Bennoun M., Porteu A., Mativet S., Beaumont C., Grandchamp B., Sirito M., Sawadogo M., Kahn A., and Vaulont S. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4596-4601
28. Rivera S., Nemeth E., Gabayan V., Lopez M.A., Farshidi D., and Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106 (2005) 2196-2199
29. Laftah A.H., Ramesh B., Simpson R.J., Solanky N., Bahram S., Schumann K., Debnam E.S., and Srai S.K. Effect of hepcidin on intestinal iron absorption in mice. Blood 103 (2004) 3940-3944
30. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J., Paw B.H., Drejer A., Barut B., Zapata A., Law T.C., Brugnara C., Lux S.E., Pinkus G.S., Pinkus J.L., Kingsley P.D., Palis J., Fleming M.D., Andrews N.C., and Zon L.I. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403 (2000) 776-781
31. McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., Miret S., Bomford A., Peters T.J., Farzaneh F., Hediger M.A., Hentze M.W., and Simpson R.J. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5 (2000) 299-309
32. Abboud S., and Haile D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275 (2000) 19906-19912
33. Zoller H., Koch R.O., Theurl I., Obrist P., Pietrangelo A., Montosi G., Haile D.J., Vogel W., and Weiss G. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 120 (2001) 1412-1419
34. Zoller H., Pietrangelo A., Vogel W., and Weiss G. Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet 353 (1999) 2120-2123
35. Yamaji S., Tennant J., Tandy S., Williams M., Singh Srai S.K., and Sharp P. Zinc regulates the function and expression of the iron transporters DMT1 and IREG1 in human intestinal Caco-2 cells. FEBS Lett. 507 (2001) 137-141
36. Yang F., Wang X., Haile D.J., Piantadosi C.A., and Ghio A.J. Iron increases expression of iron-export protein MTP1 in lung cells. Am. J. Physiol.: Lung Cell. Mol. Physiol. 283 (2002) L932-L939
37. Martini L.A., Tchack L., and Wood R.J. Iron treatment downregulates DMT1 and IREG1 mRNA expression in Caco-2 cells. J. Nutr. 132 (2002) 693-696
38. Lymboussaki A., Pignatti E., Montosi G., Garuti C., Haile D.J., and Pietrangelo A. The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression. J. Hepatol. 39 (2003) 710-715
39. Frazer D.M., Wilkins S.J., Becker E.M., Vulpe C.D., McKie A.T., Trinder D., and Anderson G.J. Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 123 (2002) 835-844
40. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
41. Nemeth E., Preza G.C., Jung C.L., Kaplan J., Waring A.J., and Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 107 (2006) 328-332
42. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., Beaumont C., Kahn A., and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110 (2002) 1037-1044
43. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
44. Lee P., Peng H., Gelbart T., and Beutler E. The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta2-microglobulin-deficient hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9263-9265
45. Lee P., Peng H., Gelbart T., Wang L., and Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1906-1910
46. Bridle K.R., Frazer D.M., Wilkins S.J., Dixon J.L., Purdie D.M., Crawford D.H., Subramaniam V.N., Powell L.W., Anderson G.J., and Ram G.A. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361 (2003) 669-673
47. Gehrke S.G., Kulaksiz H., Herrmann T., Riedel H.D., Bents K., Veltkamp C., and Stremmel W. Expression of hepcidin in hereditary hemochromatosis: evidence for a regulation in response to serum transferrin saturation and non-transferrin-bound iron. Blood 102 (2003) 371-376
48. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (2003) 783-788
49. Montosi G., Corradini E., Garuti C., Barelli S., Recalcati S., Cairo G., Valli L., Pignatti E., Vecchi C., Ferrara F., and Pietrangelo A. Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload. Hepatology 41 (2005) 545-552
50. Lou D.Q., Lesbordes J.C., Nicolas G., Viatte L., Bennoun M., Van Rooijen N., Kahn A., Renia L., and Vaulont S. Iron- and inflammation-induced hepcidin gene expression in mice is not mediated by Kupffer cells in vivo. Hepatology 41 (2005) 1056-1064
51. Lebron J.A., Bennett M.J., Vaughn D.E., Chirino A.J., Snow P.M., Mintier G.A., Feder J.N., and Bjorkman P.J. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93 (1998) 111-123
52. Rohrlich P.S., Fazilleau N., Ginhoux F., Firat H., Michel F., Cochet M., Laham N., Roth M.P., Pascolo S., Nato F., Coppin H., Charneau P., Danos O., Acuto O., Ehrlich R., Kanellopoulos J., and Lemonnier F.A. Direct recognition by alphabeta cytolytic T cells of Hfe, a Mhemochromatosis class Ib molecule without antigen-presenting function. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 12855-12860
53. Feder J.N., Penny D.M., Irrinki A., Lee V.K., Lebrón J.A., Watson N., Tsuchihashi Z., Sigal E., Bjorkman P.J., and Schatzman R.C. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 1472-1477
54. Gross C.N., Irrinki A., Feder J.N., and Enns C.A. Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implies a role in intracellular iron regulation. J. Biol. Chem. 273 (1998) 22068-22074
55. Zhang A.S., Davies P.S., Carlson H.L., and Enns C.A. Mechanisms of HFE-induced regulation of iron homeostasis: Insights from the W81A HFE mutation. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 9500-9505
56. Davies P.S., Zhang A.S., Anderson E.L., Roy C.N., Lampson M.A., McGraw T.E., and Enns C.A. Evidence for the interaction of the hereditary haemochromatosis protein, HFE, with the transferrin receptor in endocytic compartments. Biochem. J. 373 (2003) 145-153
57. Carlson H., Zhang A.S., Fleming W.H., and Enns C.A. The hereditary hemochromatosis protein, HFE, lowers intracellular iron levels independently of transferrin receptor 1 in TRVb cells. Blood 105 (2005) 2564-2570
58. Waheed A., Parkkila S., Zhou X.Y., Tomatsu S., Tsuchihashi Z., Feder J.N., Schatzman R.C., Britton R.S., Bacon B.R., and Sly W.S. Hereditary hemochromatosis: effects of C282Y and H63D mutations on association with beta(2)-microglobulin, intracellular processing, and cell surface expression of the HFE protein in COS-7 cells. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12384-12389
59. Kawabata H., Yang R., Hirama T., Vuong P.T., Kawano S., Gombart A.F., and Koeffler H.P. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J. Biol. Chem. 274 (1999) 20826-20832
60. Kawabata H., Germain R.S., Vuong P.T., Nakamaki T., Said J.W., and Koeffler H.P. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J. Biol. Chem. 275 (2000) 16618-16625
61. West Jr. A.P., Bennett M.J., Sellers V.M., Andrews N.C., Enns C.A., and Bjorkman P.J. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J. Biol. Chem. 275 (2000) 38135-38138
62. Huang F.W., Pinkus J.L., Pinkus G.S., Fleming M.D., and Andrews N.C. A mouse model of juvenile hemochromatosis. J. Clin. Invest. 115 (2005) 2187-2191
63. Niederkofler V., Salie R., and Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J. Clin. Invest. 115 (2005) 2180-2186
64. Lin L., Goldberg Y.P., and Ganz T. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106 (2005) 2884-2889
65. Wang R.H., Li C., Xu X., Zheng Y., Xiao C., Zerfas P., Cooperman S., Eckhaus M., Rouault T., Mishra L., and Deng C.X. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2 (2005) 399-409
66. Nemeth E., Roetto A., Garozzo G., Ganz T., and Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 105 (2005) 1803-1806
67. Muckenthaler M., Roy C.N., Custodio A.O., Minana B., deGraaf J., Montross L.K., Andrews N.C., and Hentze M.W. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat. Genet. 34 (2003) 102-107
68. Kawabata H., Fleming R.E., Gui D., Moon S.Y., Saitoh T., O'Kelly J., Umehara Y., Wano Y., Said J.W., and Koeffler H.P. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 105 (2005) 376-381
69. Nicolas G., Viatte L., Lou D.Q., Bennoun M., Beaumont C., Kahn A., Andrews N.C., and Vaulont S. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat. Genet. 34 (2003) 97-101
70. Rochette J., Pointon J.J., Fisher C.A., Perera G., Arambepola M., Arichchi D.S., De S.S., Vandwalle J.L., Monti J.P., Old J.M., Merryweather C.A.T., Weatherall D.J., and Robson K.J. Multicentric origin of hemochromatosis gene (HFE) mutations [published erratum appears in Am. J. Hum. Genet. 1999 May; 64(5):1491]. Am. J. Hum. Genet. 64 (1999) 1056-1062
71. Beutler E. The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis. Blood 101 (2003) 3347-3350
72. Gochee P.A., Powell L.W., Cullen D.J., Du Sart D., Rossi E., and Olynyk J.K. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation. Gastroenterology 122 (2002) 646-651
73. Pietrangelo A., Montosi G., Totaro A., Garuti C., Conte D., Cassanelli S., Fraquelli M., Sardini C., Vasta F., and Gasparini P. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene [see comments]. N. Engl. J. Med. 341 (1999) 725-732
74. Corradini E., Montosi G., Ferrara F., Caleffi A., Pignatti E., Barelli S., Garuti C., and Pietrangelo A. Lack of enterocyte iron accumulation in the ferroportin disease. Blood Cells Mol. Dis. 35 (2005) 315-318
75. Sham R.L., Phatak P.D., West C., Lee P., Andrews C., and Beutler E. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol. Dis. 34 (2005) 157-161
76. Drakesmith H., Schimanski L.M., Ormerod E., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., Bastin J.M., Cowley D., Chinthammitr Y., Robson K.J., and Townsend A.R. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106 (2005) 1092-1097
77. Schimanski L.M., Drakesmith H., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., Bastin J.M., Cowley D., Chinthammitr Y., Robson K.J., and Townsend A.R. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105 (2005) 4096-4102
78. De Domenico I., Ward D.M., Nemeth E., Vaughn M.B., Musci G., Ganz T., and Kaplan J. The molecular basis of ferroportin-linked hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8955-8960
79. Beaumont C., Leneuve P., Devaux I., Scoazec J.Y., Berthier M., Loiseau M.N., Grandchamp B., and Bonneau D. Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract. Nat. Genet. 11 (1995) 444-446
80. Girelli D., Corrocher R., Bisceglia L., Olivieri O., De Franceschi L., Zelante L., and Gasparini P. Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation"). Blood 86 (1995) 4050-4053
81. Yoshida K., Furihata K., Takeda S., Nakamura A., Yamamoto K., Morita H., Hiyamuta S., Ikeda S., Shimizu N., and Yanagisawa N. A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat. Genet. 9 (1995) 267-272
82. Harris Z.L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R.T., and Gitlin J.D. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 2539-2543
83. Babitt J.L., Huang W., Wrighting M., Xia Y., Sidis Y., Samad A., Campagna A., Chung T., Schneyer L., Woolf J., Andrews C., and Lin Y. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38 (2006) 531-539